Improving the prescribing and use of pain relievers – all prescription drugs, in fact – is a necessity. It should rest in the hands of those with authority and experience on the matter: medical and pharmacy boards, professional societies, and patient advocacy organizations, among others. The FDA, in focusing its efforts on these matters, is being distracted from its core responsibilities: expediting the development of innovative medicines, and evaluating them with urgency to meet public health needs. If the FDA focuses its attention on making safer medications available to prescribers, it can make a real difference in the lives of patients with dire medical needs and, indeed, all of us affected by prescription drug abuse.
Firefox recommends the PDF Plugin for Mac OS X for viewing PDF documents in your browser.
We can also show you Legal Updates using the Google Viewer; however, you will need to be logged into Google Docs to view them.
Please choose one of the above to proceed!
LOADING PDF: If there are any problems, click here to download the file.
Health Law Updates, Administrative Law Updates
DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
© Michael Barnes, DCBA Law & Policy | Attorney Advertising